These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19066612)

  • 1. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.
    Verschuur EM; Steyerberg EW; Tilanus HW; Polinder S; Essink-Bot ML; Tran KT; van der Gaast A; Stassen LP; Kuipers EJ; Siersema PD
    Br J Cancer; 2009 Jan; 100(1):70-6. PubMed ID: 19066612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse-led follow-up at home vs. conventional medical outpatient clinic follow-up in patients with incurable upper gastrointestinal cancer: a randomized study.
    Uitdehaag MJ; van Putten PG; van Eijck CH; Verschuur EM; van der Gaast A; Pek CJ; van der Rijt CC; de Man RA; Steyerberg EW; Laheij RJ; Siersema PD; Spaander MC; Kuipers EJ
    J Pain Symptom Manage; 2014 Mar; 47(3):518-30. PubMed ID: 23880585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost comparison study of two different follow-up protocols after surgery for oesophageal cancer.
    Polinder S; Verschuur EM; Siersema PD; Kuipers EJ; Steyerberg EW
    Eur J Cancer; 2009 Aug; 45(12):2110-5. PubMed ID: 19398325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life for patients with esophageal/gastric cardia precursor lesions or cancer: a one-year prospective study.
    Wen Y; Pan XF; Huang WZ; Zhao ZM; Wei WQ; Chen F; Lan H; Huang H; Yang CX; Qiao YL
    Asian Pac J Cancer Prev; 2015; 16(1):45-51. PubMed ID: 25640389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
    Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
    Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial.
    Moore S; Corner J; Haviland J; Wells M; Salmon E; Normand C; Brada M; O'Brien M; Smith I
    BMJ; 2002 Nov; 325(7373):1145. PubMed ID: 12433764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia.
    Blazeby JM; Metcalfe C; Nicklin J; Barham CP; Donovan J; Alderson D
    Br J Surg; 2005 Dec; 92(12):1502-7. PubMed ID: 16252311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.
    McKernan M; McMillan DC; Anderson JR; Angerson WJ; Stuart RC
    Br J Cancer; 2008 Mar; 98(5):888-93. PubMed ID: 18268490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical function and quality of life after thoracoabdominal oesophageal resection. Results of a follow-up study.
    Fagevik Olsén M; Larsson M; Hammerlid E; Lundell L
    Dig Surg; 2005; 22(1-2):63-8. PubMed ID: 15838174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and persisting symptoms after oesophageal cancer surgery.
    Viklund P; Wengström Y; Rouvelas I; Lindblad M; Lagergren J
    Eur J Cancer; 2006 Jul; 42(10):1407-14. PubMed ID: 16737812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy.
    Faithfull S; Corner J; Meyer L; Huddart R; Dearnaley D
    Br J Cancer; 2001 Dec; 85(12):1853-64. PubMed ID: 11747326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review.
    Lewis R; Neal RD; Williams NH; France B; Wilkinson C; Hendry M; Russell D; Russell I; Hughes DA; Stuart NS; Weller D
    J Adv Nurs; 2009 Apr; 65(4):706-23. PubMed ID: 19278415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with cancer of the esophagus and gastric cardia: a case for palliative resection.
    Branicki FJ; Law SY; Fok M; Poon RT; Chu KM; Wong J
    Arch Surg; 1998 Mar; 133(3):316-22. PubMed ID: 9517747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial.
    Kimman ML; Dirksen CD; Voogd AC; Falger P; Gijsen BC; Thuring M; Lenssen A; van der Ent F; Verkeyn J; Haekens C; Hupperets P; Nuytinck JK; van Riet Y; Brenninkmeijer SJ; Scheijmans LJ; Kessels A; Lambin P; Boersma LJ
    Eur J Cancer; 2011 May; 47(7):1027-36. PubMed ID: 21237636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.